What Is Somatic Psychedelic Facilitation?
Somatic psychedelic facilitation (SPF) is a body-centered approach to psychedelic-assisted care that integrates somatic awareness practices with the therapeutic window opened by a psychedelic medicine — in this case, ketamine. Where many ketamine clinics focus almost entirely on pharmacology and infusion delivery, somatic facilitation adds a layer of intentional body-based guidance before, during, and after the medicine session.
The word somatic comes from the Greek soma, meaning body. Somatic therapies proceed from the understanding that trauma, chronic stress, and depression are not purely cognitive or emotional phenomena — they are also held in the body as patterns of tension, posture, sensation, and physiological dysregulation. Talk therapy alone often reaches a ceiling with patients who carry this kind of somatized burden. Somatic facilitation aims to work beneath that ceiling.
When ketamine is introduced into a somatic framework, the medicine’s capacity to temporarily dissolve habitual mental patterns can allow a patient to access body-held material that would otherwise remain defended against. The facilitator’s role is to help the patient stay oriented, titrate their experience, and begin integrating what arises — not as an abstract insight, but as a felt shift in the body.
How Cassidy Boyer Approaches Somatic Psychedelic Facilitation
Cassidy Boyer, CRNA, is the provider behind Mend the Mind in Livingston, MT. Her background combines two distinct skill sets that are rarely held by a single practitioner: the pharmacological precision of a Certified Registered Nurse Anesthetist and formal training in somatic facilitation methods.
As a CRNA, Cassidy brings clinical rigor to every aspect of ketamine administration — dosing, monitoring, safety screening, and physiological management during sessions. That medical foundation is non-negotiable. But it is her somatic training that shapes how sessions are structured, how preparation conversations are held, and how integration work is supported after the medicine experience.
In practice, Cassidy’s approach to somatic psychedelic facilitation typically involves three phases:
1. Preparation
Before any medicine is introduced, Cassidy meets with patients to establish safety, review relevant history, and — critically — begin cultivating somatic awareness. This might involve learning to track body sensations, identifying areas of chronic holding or tension, and developing a basic orientation practice that the patient can return to during the session if they feel overwhelmed. Preparation is not a formality. It is clinical groundwork that significantly shapes what becomes possible during the session itself.
2. The Facilitated Session
Ketamine is administered — either via IV infusion or sublingual troches, depending on what is clinically appropriate — in a supported environment. Cassidy remains present throughout, offering grounding cues, breathwork prompts, or gentle orienting language as needed. The goal is not to direct the patient’s experience, but to provide a stable relational field in which the patient can go deeper without becoming dysregulated. Medical monitoring continues throughout.
3. Integration
Integration is where somatic facilitation diverges most visibly from standard ketamine infusion care. Rather than simply tracking symptom scores after a session, Cassidy works with patients to help them make meaning of what arose — and, more importantly, to anchor any perceptual or physiological shifts into sustainable changes in daily life. This may involve body-mapping exercises, movement practices, or coordination with a patient’s existing therapist.
Who Is Somatic Psychedelic Facilitation For?
SPF is not the right fit for every patient who walks through the door. Cassidy approaches candidacy thoughtfully and honestly. That said, certain presentations tend to be particularly well-served by this modality.
Patients Who Have Reached the Limits of Verbal Therapy
Many patients arrive at Mend the Mind after years of psychotherapy — sometimes excellent therapy — that has produced significant insight but limited relief from depression, anxiety, or PTSD. These patients often describe knowing intellectually what happened to them and understanding its effects, but feeling unable to move the experience out of the body. Somatic facilitation with ketamine is designed specifically for this kind of impasse.
Patients with Somatized Trauma
Trauma that has been chronically suppressed or that occurred before the development of verbal memory frequently lives in the body rather than in narrative. Patients with complex PTSD, early developmental trauma, or chronic stress responses that manifest as physical symptoms — pain, fatigue, digestive disruption, hypervigilance — may find that body-centered approaches reach material that cognitive work alone cannot.
PTSD Patients with Physical Expression
For patients whose PTSD manifests significantly in the body — startle responses, chronic muscle bracing, somatic flashbacks, or dissociative episodes with physical components — the combination of ketamine’s dissociative-resetting properties and somatic facilitation’s grounding orientation can offer a pathway that neither approach provides alone. Cassidy’s PTSD treatment approach draws on this integration directly.
Patients Seeking Depth, Not Just Pharmacology
Some patients have already had ketamine infusions elsewhere and experienced symptom relief, but feel something was missing — a sense that the door opened but no one helped them walk through it. SPF is designed for patients who want the medicine experience to mean something, to connect to their larger healing trajectory rather than exist as a standalone intervention.
Why Cassidy Offers This in Livingston, MT
Montana has a psychiatrist shortage that is severe even by rural American standards. Livingston and the broader Yellowstone River Valley are home to residents whose mental health needs are real, complex, and chronically underserved. The combination of geographic isolation, cultural barriers to help-seeking, and limited specialty care supply creates a situation in which patients often arrive at Mend the Mind having exhausted every option available to them locally.
Cassidy built her practice around this reality. Offering somatic psychedelic facilitation in Livingston is not a marketing choice — it reflects a clinical judgment that the patients she sees need more than pharmacology, and that the body-centered component of care is not optional for many of them.
There is also a practical consideration: in a state where the nearest large psychiatric center may be hours away and where telehealth has significant limitations for complex presentations, having a single provider who can hold both the medical and the facilitation dimensions of ketamine care matters. Patients do not need to coordinate between a prescribing CRNA and a separate ketamine therapist. Cassidy holds both roles, and the continuity of that relationship is itself therapeutically significant.
What Medicines Are Used?
Mend the Mind uses ketamine as the primary medicine in somatic psychedelic facilitation. Ketamine is used off-label for psychiatric and somatic indications in this context; it is not FDA-approved for these uses. Individual results vary.
Depending on clinical assessment, Cassidy may use IV ketamine for in-clinic sessions, which allows precise dosing and direct monitoring, or ketamine troches (sublingual lozenges) for lower-intensity supported sessions. The choice of delivery method is made collaboratively with each patient based on their history, goals, and clinical presentation.
How Does SPF Differ from Standard Ketamine Infusion Therapy?
Standard ketamine infusion clinics — of which there are now many across the country — typically offer a medical procedure: a nurse or anesthetist monitors the patient during an IV infusion, and the patient is discharged once the session is complete. Some clinics add a brief check-in before or after. Few offer structured preparation or integration, and fewer still incorporate somatic methods.
Somatic psychedelic facilitation at Mend the Mind is built around the premise that the medicine session is the middle of the work, not the entirety of it. Preparation and integration are not optional add-ons — they are core to the clinical framework. This distinction matters for outcomes, and it matters particularly for the patient populations Cassidy serves, where the therapeutic relationship and the body-centered work often do as much as the ketamine itself.
Frequently Asked Questions
Is somatic psychedelic facilitation the same as ketamine-assisted psychotherapy?
They overlap significantly but are not identical. Ketamine-assisted psychotherapy (KAP) typically involves a licensed therapist holding the psychotherapeutic frame, with ketamine used to enhance therapeutic access. Somatic psychedelic facilitation emphasizes body-centered awareness and somatic processing as the primary therapeutic modality. In Cassidy’s practice, these approaches inform each other, and many patients receive elements of both.
Do I need to have done ketamine before to try SPF?
No. Many patients come to somatic psychedelic facilitation with no prior ketamine experience. Cassidy’s preparation process is designed to orient new patients to both the medicine and the somatic framework before any session occurs.
Is ketamine safe?
Ketamine has a well-established safety profile when administered by a qualified medical provider. As a CRNA, Cassidy brings anesthesia-level pharmacological training to every session. That said, ketamine is not appropriate for everyone, and Cassidy conducts thorough screening before proceeding with any patient. Ketamine use in this context is off-label, and results vary by individual.
Does insurance cover somatic psychedelic facilitation?
Mend the Mind is an out-of-network provider. Superbills are provided so patients can seek reimbursement through their insurance where applicable. Patients are encouraged to verify their out-of-network mental health benefits before beginning care.
How do I find out if I’m a good candidate?
The first step is a consultation with Cassidy. She reviews each patient’s clinical history, prior treatment trajectory, and current goals before making any recommendation. To get started, schedule a consultation with the Mend the Mind team.
References
Corrigan, F. M., Fisher, J., & Nutt, D. J. (2011). Autonomic dysregulation and the Window of Tolerance model of the effects of complex emotional trauma. Journal of Psychopharmacology, 25(1), 17–25. https://doi.org/10.1177/0269881109354930
Levine, P. A. (2010). In an Unspoken Voice: How the Body Releases Trauma and Restores Goodness. North Atlantic Books.
Dore, J., Turnipseed, B., Dwyer, S., Turnipseed, A., Andries, J., Ascani, G., Monnette, C., Huidekoper, A., Strauss, N., & Wolfson, P. (2019). Ketamine assisted psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy. Journal of Psychoactive Drugs, 51(2), 189–198. https://doi.org/10.1080/02791072.2019.1587556
van der Kolk, B. A. (2014). The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. Viking.
Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., Kirkwood, K., Aan Het Rot, M., Lapidus, K. A., Wan, L. B., Iosifescu, D., & Charney, D. S. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 71(6), 681–688. https://doi.org/10.1001/jamapsychiatry.2014.62